NEW YORK (GenomeWeb) – EKF Molecular Diagnostics will collaborate with medical technology firm Angle for liquid biopsy development, the companies announced today.

The UK-headquartered companies aim to initially investigate applications for colorectal cancer diagnostics combining EKF's PointMan DNA enrichment technology with Angle’s Parsortix circulating tumor cell (CTC) harvesting platform.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.